TECHNELITE
LOE Approachingtechnetium tc99m generator
NDAINTRAVENOUSSOLUTION
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNELITE (technetium tc99m generator) is radiopharmaceutical activity [moa]. First approved in 1976.
Drug data last refreshed 3h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECHNELITE is a technetium Tc-99m generator, a radiopharmaceutical diagnostic agent used to produce Tc-99m radioisotopes for medical imaging procedures. It operates via radiopharmaceutical activity, enabling real-time visualization of organ function and blood flow. This is a foundational diagnostic tool in nuclear medicine, approved since 1976.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30%), suggesting transition planning and potential team restructuring within the next 1-2 years.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TECHNELITE offers limited growth opportunity as the product approaches loss of exclusivity with zero linked job openings. Career development would focus on mature product management, cost containment, and transition planning rather than expansion or launch activities.
Product ManagerCommercial Operations
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.